1. Home
  2. FHTX vs MUX Comparison

FHTX vs MUX Comparison

Compare FHTX & MUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FHTX
  • MUX
  • Stock Information
  • Founded
  • FHTX 2015
  • MUX 1979
  • Country
  • FHTX United States
  • MUX Canada
  • Employees
  • FHTX N/A
  • MUX N/A
  • Industry
  • FHTX Medicinal Chemicals and Botanical Products
  • MUX Precious Metals
  • Sector
  • FHTX Health Care
  • MUX Basic Materials
  • Exchange
  • FHTX Nasdaq
  • MUX Nasdaq
  • Market Cap
  • FHTX 271.5M
  • MUX 518.8M
  • IPO Year
  • FHTX 2020
  • MUX N/A
  • Fundamental
  • Price
  • FHTX $5.40
  • MUX $10.91
  • Analyst Decision
  • FHTX Strong Buy
  • MUX Strong Buy
  • Analyst Count
  • FHTX 8
  • MUX 2
  • Target Price
  • FHTX $12.63
  • MUX $15.25
  • AVG Volume (30 Days)
  • FHTX 146.4K
  • MUX 967.7K
  • Earning Date
  • FHTX 08-07-2025
  • MUX 08-06-2025
  • Dividend Yield
  • FHTX N/A
  • MUX N/A
  • EPS Growth
  • FHTX N/A
  • MUX N/A
  • EPS
  • FHTX N/A
  • MUX N/A
  • Revenue
  • FHTX $23,504,000.00
  • MUX $168,945,000.00
  • Revenue This Year
  • FHTX $33.60
  • MUX N/A
  • Revenue Next Year
  • FHTX $5.87
  • MUX $0.31
  • P/E Ratio
  • FHTX N/A
  • MUX N/A
  • Revenue Growth
  • FHTX N/A
  • MUX N/A
  • 52 Week Low
  • FHTX $2.95
  • MUX $6.38
  • 52 Week High
  • FHTX $10.25
  • MUX $11.46
  • Technical
  • Relative Strength Index (RSI)
  • FHTX 64.55
  • MUX 65.74
  • Support Level
  • FHTX $4.78
  • MUX $10.36
  • Resistance Level
  • FHTX $5.52
  • MUX $11.45
  • Average True Range (ATR)
  • FHTX 0.32
  • MUX 0.49
  • MACD
  • FHTX 0.05
  • MUX 0.04
  • Stochastic Oscillator
  • FHTX 86.67
  • MUX 78.17

About FHTX Foghorn Therapeutics Inc.

Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing it to identify, validate, and potentially drug targets within the system. The company is developing FHD-286, a selective, allosteric ATPase inhibitor, and FHD-609, a protein degrader, to treat hematologic cancers and solid tumors.

About MUX McEwen Mining Inc.

McEwen Mining Inc is a mining and minerals production and exploration company that focuses on precious and base minerals in Argentina, Mexico, and the United States. The company primarily generates its revenue from gold and silver production. It owns and operates the wholly-owned El Gallo 1 mine in Mexico and holds a minority stake in the company that manages the San Jose mine in Argentina. More than half of the company's gold output comes from the El Gallo 1 mine, while the remaining gold production and the majority of silver production are sourced from the San Jose mine. Geographically, most production occurs in the United States.

Share on Social Networks: